His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches
Tirzepatide approval for type 2 diabetes and obesity
Includes TB-500 and BPC-157
ED Meds: Be careful taking these with PDE-5 inhibitors (like Sildenafil), as the combination can cause blood pressure to drop too low
This rapid response makes sense given that intravenous glutathione bypasses metabolic barriers entirely, flooding cells with a usable antioxidant almost immediately
Orlistat is indicated as an adjunct to a reduced-calorie diet for weight management in specific adult populations
